Gene · 3568
Papers2,231
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 2,231
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Interleukin-5 levels in relation to malaria severity: a systematic review. | Malar J | 2023 | 37537570 | PubTator, text mining | PubMed |
| Challenges and Future Trends in Atopic Dermatitis. | Int J Mol Sci | 2023 | 37511138 | PubTator, text mining | PubMed |
| Candidate Gene Association Studies in Atopic Dermatitis in Participants of European and Asian Ancestry: A Systematic Review and Meta-Analysis. | Genes (Basel) | 2023 | 37510360 | PubTator, text mining | PubMed |
| Interleukin 5 Receptor Subunit Alpha Expression as a Potential Biomarker in Patients with Nasal Polyposis. | Biomedicines | 2023 | 37509606 | PubTator, text mining | PubMed |
| The minichromosome maintenance complex drives esophageal basal zone hyperplasia. | JCI Insight | 2023 | 37490338 | PubTator, text mining | PubMed |
| Eosinophils as potential biomarkers in respiratory viral infections. | Front Immunol | 2023 | 37483591 | PubTator, text mining | PubMed |
| Efficacy and safety of CM310 in severe eosinophilic chronic rhinosinusitis with nasal polyps (CROWNS-1): a multicentre, randomised, double-blind, placebo-controlled phase 2 clinical trial. | EClinicalMedicine | 2023 | 37483544 | PubTator, text mining | PubMed |
| Emerging Landscape of Nanobodies and Their Neutralizing Applications against SARS-CoV-2 Virus. | ACS Pharmacol Transl Sci | 2023 | 37470012 | PubTator, text mining | PubMed |
| Basophils in pruritic skin diseases. | Front Immunol | 2023 | 37465674 | PubTator, text mining | PubMed |
| Landscape of mast cell populations across organs in mice and humans. | J Exp Med | 2023 | 37462672 | PubTator, text mining | PubMed |
| Lysine butyrylation of HSP90 regulated by KAT8 and HDAC11 confers chemoresistance. | Cell Discov | 2023 | 37460462 | PubTator, text mining | PubMed |
| Effectiveness and safety of anti-IL-5/Rα biologics in eosinophilic granulomatosis with polyangiitis: a two-year multicenter observational study. | Front Immunol | 2023 | 37457743 | PubTator, text mining | PubMed |
| Targeting transcription factors for therapeutic benefit in rheumatoid arthritis. | Front Immunol | 2023 | 37457726 | PubTator, text mining | PubMed |
| Advances in understanding of the pathogenesis and therapeutic implications of drug reaction with eosinophilia and systemic symptoms: an updated review. | Front Med (Lausanne) | 2023 | 37457584 | PubTator, text mining | PubMed |
| Type 1 and type 2 cytokine-mediated immune orchestration in the tumour microenvironment and their therapeutic potential. | Explor Target Antitumor Ther | 2023 | 37455828 | PubTator, text mining | PubMed |
| Diseases from the Spectrum of Dermatitis and Eczema: Can "Omics" Sciences Help with Better Systematics and More Accurate Differential Diagnosis? | Int J Mol Sci | 2023 | 37445645 | PubTator, text mining | PubMed |
| Macrophages Orchestrate Airway Inflammation, Remodeling, and Resolution in Asthma. | Int J Mol Sci | 2023 | 37445635 | PubTator, text mining | PubMed |
| Benralizumab in Patients with Severe Eosinophilic Asthma: A Multicentre Real-Life Experience. | J Clin Med | 2023 | 37445397 | PubTator, text mining | PubMed |
| Evidence-Based Approach of Biologic Therapy in Bronchial Asthma. | J Clin Med | 2023 | 37445357 | PubTator, text mining | PubMed |
| Emerging Biosensing Methods to Monitor Lung Cancer Biomarkers in Biological Samples: A Comprehensive Review. | Cancers (Basel) | 2023 | 37444523 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3568/papers?page=17